Literature DB >> 29987574

Mathematical analysis and drug exposure evaluation of pharmacokinetic models with endogenous production and simultaneous first-order and Michaelis-Menten elimination: the case of single dose.

Xiaotian Wu1,2, Fahima Nekka3,4, Jun Li2,5.   

Abstract

Drugs with an additional endogenous source often exhibit simultaneous first-order and Michaelis-Menten elimination and are becoming quite common in pharmacokinetic modeling. In this paper, we investigate the case of single dose intravenous bolus administration for the one-compartment model. Relying on a formerly introduced transcendent function, we were able to analytically express the concentration time course of this model and provide the pharmacokinetic interpretation of its components. Using the concept of the corrected concentration, the mathematical expressions for the partial and total areas under the concentration time curve (AUC) were also given. The impact on the corrected concentration and AUC is discussed as well as the relative contribution of the exogenous part in presence of endogenous production. The present findings theoretically elucidate several pharmacokinetic issues for the considered drug compounds and provide guidance for the rational estimation of their pharmacokinetic parameters.

Keywords:  Area under the concentration time curve (AUC); Endogenous production; Pharmacokinetic model; Simultaneous first-order and Michaelis–Menten elimination; X function

Mesh:

Substances:

Year:  2018        PMID: 29987574     DOI: 10.1007/s10928-018-9599-4

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  27 in total

1.  Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives.

Authors:  H Derendorf; B Meibohm
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

2.  Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-07-12       Impact factor: 2.745

3.  Asymptotic Analysis of a Target-Mediated Drug Disposition Model: Algorithmic and Traditional Approaches.

Authors:  Dimitris G Patsatzis; Dimitris T Maris; Dimitris A Goussis
Journal:  Bull Math Biol       Date:  2016-06-08       Impact factor: 1.758

4.  Computation of the explicit solution to the Michaelis-Menten equation.

Authors:  S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

5.  Population modeling of filgrastim PK-PD in healthy adults following intravenous and subcutaneous administrations.

Authors:  Wojciech Krzyzanski; Pawel Wiczling; Phil Lowe; Etienne Pigeolet; Martin Fink; Alexander Berghout; Sigrid Balser
Journal:  J Clin Pharmacol       Date:  2010-09       Impact factor: 3.126

Review 6.  Induction and regulation of endogenous granulocyte colony-stimulating factor formation.

Authors:  Lars Hareng; Thomas Hartung
Journal:  Biol Chem       Date:  2002-10       Impact factor: 3.915

Review 7.  Romiplostim: a novel thrombopoiesis-stimulating agent.

Authors:  Sarah Perreault; Julianna Burzynski
Journal:  Am J Health Syst Pharm       Date:  2009-05-01       Impact factor: 2.637

8.  Mathematical model for G-CSF administration after chemotherapy.

Authors:  Catherine Foley; Michael C Mackey
Journal:  J Theor Biol       Date:  2008-11-01       Impact factor: 2.691

9.  One-compartment model with Michaelis-Menten elimination kinetics and therapeutic window: an analytical approach.

Authors:  Sanyi Tang; Yanni Xiao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-09-15       Impact factor: 2.410

10.  Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

Authors:  Markus Scholz; Sibylle Schirm; Marcus Wetzler; Christoph Engel; Markus Loeffler
Journal:  Theor Biol Med Model       Date:  2012-07-30       Impact factor: 2.432

View more
  1 in total

1.  Oral drug delivery systems using core-shell structure additive manufacturing technologies: a proof-of-concept study.

Authors:  Jiaxiang Zhang; Pengchong Xu; Anh Q Vo; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2021-03-04       Impact factor: 3.765

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.